Who Just RaisedRamat Gan, Israel · Health Care · Form D filed Sep 10, 2026
Can-Fite BioPharma Ltd. raised $8.3M
Can-Fite BioPharma Ltd. is a pharmaceutical company based in Ramat Gan, Israel. In a Form D filed with the SEC on September 10, 2026, it reported raising $8,306,884 from 1 investor as part of an offering of up to $8,306,884. The first sale in the offering took place on September 2, 2026.
- 15th Form D since 2014. Earlier new notices: Dec 30, 2021 · Aug 26, 2021 · Jul 17, 2020 · Jun 19, 2020 · Jan 24, 2020 · May 31, 2019 and more. All filings on EDGAR
$42.1M raised since 2020
6 Form D offerings, as reported to the SEC, the first in Jan 24, 2020. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Sep 10, 2026 | $8.3M | $8.3M | 1 |
| Dec 30, 2021 | $10M | $10M | 1 |
| Aug 26, 2021 | $10M | $10M | 1 |
| Jul 17, 2020 | $3.4M | $3.4M | 3 |
| Jun 19, 2020 | $8M | $8M | 4 |
| Jan 24, 2020 | $2.4M | $2.4M | 4 |
Placement agent: H.C. Wainwright & Co., LLC
Lead score
11 out of 100
budget to spend
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Amount raised
- $8,306,884
- Offering size
- $8,306,884
- Investors so far
- 1
- First sale
- September 2, 2026
- Securities offered
- Equity, Options or warrants, Securities issuable on exercise or conversion
- Exemption claimed
- Rule 506(b)
- Industry
- Pharmaceuticals
- Headquarters
- Ramat Gan, Israel
- Incorporated
- Israel
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $8,306,884 | $8,306,884 | 1 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Sep 7, 2026 · September 2026 funding report
Similar raises
Estuary Biotherapeutics, Inc.
Menlo Park, CA · filed Oct 16First Form DStill raising
North Elam Ambulatory Surgery Center, LLC
Greensboro, NC · filed Oct 16First Form DStill raising
Immorta Bio, Inc.
Miami Beach, FL · filed Oct 162nd Form D since 2026Still raising
Lamina Surgical, Inc.
Oakland, CA · filed Oct 16
Making Open Surgery Safer | Lamina
First Form DStill raising
J3 Bioscience, Inc.
Salt Lake City, UT · filed Oct 1612th Form D since 2012
Ensho Therapeutics, Inc.
Woodcliff Lake, NJ · filed Oct 155th Form D since 2024Still raising
Light Wave Ownership Path, LLC
Raleigh, NC · filed Oct 1512th Form D since 2019
Immuno Cancer Biotherapeutics, Inc.
Canton, SD · filed Oct 15First Form D